Table 4. Factors associated with treatment success among adult TB patients.

Characteristic	Crude OR		Adjusted OR
	OR (95% CI)	p-value	OR (95% CI)	p-value
Place of DOT		<0.001		<0.001
Facility-based	1 (Ref)		1 (Ref)
Home-based	0.56 (0.43–0.72)		0.53 (0.41–0.70)
Sex		0.9		0.2
Male	1 (Ref)		1 (Ref)
Female	1.0 (0.82–1.22)		1.15 (0.94–1.41)
Age groups (years)		<0.001		0.03
<25	1 (Ref)		1 (Ref)
25–34	0.79 (0.57–1.09)		0.84 (0.60–1.17)
35–44	0.60 (0.43–0.83)		0.73 (0.52–1.03)
≥45 years	0.51 (0.37–0.70)		0.63 (0.45–0.88)
HIV status		<0.001		<0.001
Negative	1 (Ref)		1 (Ref)
Positive	0.55 (0.45–0.67)		0.62 (0.50–0.77)
Unknown HIV status	0.76 (0.51–1.12)		0.81 (0.54–1.20)
Site of disease		0.046		0.7
PTB	1 (Ref)		1 (Ref)
EPTB	0.79 (0.62–0.99)		1.09 (0.84–1.41)
AFB smear results at diagnosis		<0.001		<0.001
Smear-negative	1 (Ref)		1 (Ref)
Smear-positive	1.74 (1.43–2.12)		1.61 (1.29–2.01)
Unknown	0.59 (0.27–1.29)		0.74 (0.33–1.64)
Category of TB patient		0.02		<0.001
New	1 (Ref)		1 (Ref)
Retreatment	0.45 (0.28–0.72)		0.34 (0.21–0.56)

OR, Odds Ratio; 95% CI = 95% Confidence Interval; DOT, Directly Observed Treatment; Ref, Reference Group; HIV, Human Immunodeficiency Virus; TB, Tuberculosis; PTB, Pulmonary tuberculosis; EPTB, Extra-pulmonary tuberculosis

All variables were included in the adjusted model

Excluded: Not evaluated = Transferred-out and TB patients with unknown TB treatment outcomes, n = 363, 7.5%.